AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (531.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Guideline Interpretation | Publishing Language: Chinese

Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China

Shan ZHANGJie LIU( )
Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
Show Author Information

Abstract

Primary cutaneous lymphomas are a group of non-Hodgkin's lymphomas originating from the skin, with unique clinical and histological features. In December 2023, the National Comprehensive Cancer Network (NCCN) updated and released the Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1. 2024). Compared to the 2023 edition of the Guidelines, this update mainly focuses on the principles of diagnostic assessment, staging criteria, treatment principles for mycosis fungoides(MF) at different stages, and recommendations for radiotherapy. In conjunction with the current situation and characteristics of the diagnosis and treatment of primary cutaneous lymphoma in our country, this article interprets the main recommendations of the Guidelines to promote the application of clinical practices in our country.

CLC number: R739.5 Document code: A Article ID: 1674-9081(2024)05-1029-09

References

【1】
【1】
 
 
Medical Journal of Peking Union Medical College Hospital
Pages 1029-1037

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHANG S, LIU J. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. https://doi.org/10.12290/xhyxzz.2024-0605

1050

Views

11

Downloads

0

Crossref

1

Scopus

0

CSCD

Received: 06 August 2024
Accepted: 26 August 2024
Published: 30 September 2024
© 2024 Medical Journal of Peking Union Medical College Hospital